France-based Tridem Pharma supplies antimalarial and consumer health products to African and Middle Eastern markets.
Founded in 1986 and headquartered in France, Tridem Pharma distributes pharmaceutical and healthcare products, with key markets in Ghana, Kenya, Nigeria, Tanzania and several French-speaking African countries. Its network spans over 35 countries, and it sells through B2B channels to public health agencies and private providers. Fosun Pharma acquired the company in a Trade Sale valued at EUR 63 million in October 2017. Revenue was EUR 213,663,184.60 in fiscal 2023.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in